Oral contraceptives and benign breast disease: A case-control study

Silvia Franceschi, Carlo La Vecchia, Fabio Parazzini, Monica Fasoli, Michela Regallo, Adriano Decarli, Giuseppe Gallus, Gianni Tognoni

Research output: Contribution to journalArticle

Abstract

The relationship between benign breast disease and use of oral contraceptives was analyzed in a case-control study conducted in Milan with 288 cases of clinically relevant and histologically confirmed benign breast disease and 285 age-matched controls with a spectrum of acute conditions apparently unrelated to use of oral contraceptives. Compared to the risk for women who had never used oral contraceptives, the relative risk for users was 1.0 (95% confidence interval: 0.6 to 1.5). There was no significant association with duration of use; however, a significantly lower relative risk was found in women using oral contraceptives during the year before breast biopsy (relative risk: 0.4; 95% confidence interval: 0.2 to 0.8). The protection in current users increased with increasing duration of use. In spite of this finding, the overall results of the present study do not support the hypothesis that oral contraceptive use protects against development of histologically confirmed and clinically relevant benign breast disease.

Original languageEnglish
Pages (from-to)602-606
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume149
Issue number6
DOIs
Publication statusPublished - Jul 15 1984

Fingerprint

Breast Diseases
Oral Contraceptives
Case-Control Studies
Confidence Intervals
Breast
Biopsy

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Cite this

Franceschi, S., Vecchia, C. L., Parazzini, F., Fasoli, M., Regallo, M., Decarli, A., ... Tognoni, G. (1984). Oral contraceptives and benign breast disease: A case-control study. American Journal of Obstetrics and Gynecology, 149(6), 602-606. https://doi.org/10.1016/0002-9378(84)90242-4

Oral contraceptives and benign breast disease : A case-control study. / Franceschi, Silvia; Vecchia, Carlo La; Parazzini, Fabio; Fasoli, Monica; Regallo, Michela; Decarli, Adriano; Gallus, Giuseppe; Tognoni, Gianni.

In: American Journal of Obstetrics and Gynecology, Vol. 149, No. 6, 15.07.1984, p. 602-606.

Research output: Contribution to journalArticle

Franceschi, S, Vecchia, CL, Parazzini, F, Fasoli, M, Regallo, M, Decarli, A, Gallus, G & Tognoni, G 1984, 'Oral contraceptives and benign breast disease: A case-control study', American Journal of Obstetrics and Gynecology, vol. 149, no. 6, pp. 602-606. https://doi.org/10.1016/0002-9378(84)90242-4
Franceschi, Silvia ; Vecchia, Carlo La ; Parazzini, Fabio ; Fasoli, Monica ; Regallo, Michela ; Decarli, Adriano ; Gallus, Giuseppe ; Tognoni, Gianni. / Oral contraceptives and benign breast disease : A case-control study. In: American Journal of Obstetrics and Gynecology. 1984 ; Vol. 149, No. 6. pp. 602-606.
@article{60cbf325a888463f939a88fc24d79a48,
title = "Oral contraceptives and benign breast disease: A case-control study",
abstract = "The relationship between benign breast disease and use of oral contraceptives was analyzed in a case-control study conducted in Milan with 288 cases of clinically relevant and histologically confirmed benign breast disease and 285 age-matched controls with a spectrum of acute conditions apparently unrelated to use of oral contraceptives. Compared to the risk for women who had never used oral contraceptives, the relative risk for users was 1.0 (95{\%} confidence interval: 0.6 to 1.5). There was no significant association with duration of use; however, a significantly lower relative risk was found in women using oral contraceptives during the year before breast biopsy (relative risk: 0.4; 95{\%} confidence interval: 0.2 to 0.8). The protection in current users increased with increasing duration of use. In spite of this finding, the overall results of the present study do not support the hypothesis that oral contraceptive use protects against development of histologically confirmed and clinically relevant benign breast disease.",
author = "Silvia Franceschi and Vecchia, {Carlo La} and Fabio Parazzini and Monica Fasoli and Michela Regallo and Adriano Decarli and Giuseppe Gallus and Gianni Tognoni",
year = "1984",
month = "7",
day = "15",
doi = "10.1016/0002-9378(84)90242-4",
language = "English",
volume = "149",
pages = "602--606",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Oral contraceptives and benign breast disease

T2 - A case-control study

AU - Franceschi, Silvia

AU - Vecchia, Carlo La

AU - Parazzini, Fabio

AU - Fasoli, Monica

AU - Regallo, Michela

AU - Decarli, Adriano

AU - Gallus, Giuseppe

AU - Tognoni, Gianni

PY - 1984/7/15

Y1 - 1984/7/15

N2 - The relationship between benign breast disease and use of oral contraceptives was analyzed in a case-control study conducted in Milan with 288 cases of clinically relevant and histologically confirmed benign breast disease and 285 age-matched controls with a spectrum of acute conditions apparently unrelated to use of oral contraceptives. Compared to the risk for women who had never used oral contraceptives, the relative risk for users was 1.0 (95% confidence interval: 0.6 to 1.5). There was no significant association with duration of use; however, a significantly lower relative risk was found in women using oral contraceptives during the year before breast biopsy (relative risk: 0.4; 95% confidence interval: 0.2 to 0.8). The protection in current users increased with increasing duration of use. In spite of this finding, the overall results of the present study do not support the hypothesis that oral contraceptive use protects against development of histologically confirmed and clinically relevant benign breast disease.

AB - The relationship between benign breast disease and use of oral contraceptives was analyzed in a case-control study conducted in Milan with 288 cases of clinically relevant and histologically confirmed benign breast disease and 285 age-matched controls with a spectrum of acute conditions apparently unrelated to use of oral contraceptives. Compared to the risk for women who had never used oral contraceptives, the relative risk for users was 1.0 (95% confidence interval: 0.6 to 1.5). There was no significant association with duration of use; however, a significantly lower relative risk was found in women using oral contraceptives during the year before breast biopsy (relative risk: 0.4; 95% confidence interval: 0.2 to 0.8). The protection in current users increased with increasing duration of use. In spite of this finding, the overall results of the present study do not support the hypothesis that oral contraceptive use protects against development of histologically confirmed and clinically relevant benign breast disease.

UR - http://www.scopus.com/inward/record.url?scp=0021245681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021245681&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(84)90242-4

DO - 10.1016/0002-9378(84)90242-4

M3 - Article

C2 - 6742041

AN - SCOPUS:0021245681

VL - 149

SP - 602

EP - 606

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -